Jeremy McGrath, PA
Medical · Davenport, IANPI 1790742864
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 33.4% of the total.
Across 46 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$336
- Sanofi$247
- Alk-abello, Inc$97
- Optinose US, Inc.$86
- GSK$85
- Medtronic$39
- plus $117 from 5 others
What the payments were for
- Food & beverage$1,006100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $336 |
| Sanofi | 14 | $247 |
| Alk-abello, Inc | 3 | $97 |
| Optinose US, Inc. | 4 | $86 |
| GSK | 5 | $85 |
| Medtronic | 2 | $39 |
| Convatec Inc. | 1 | $39 |
| Stryker | 1 | $26 |
| KARL Storz Endoscopy-america | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Merck | 1 | $13 |
How this compares
$1,006 in reported general payments places this provider in the 70th percentile of 141 medical providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 84 | $10,149 |
| Fluticasone Propionate | 55 | $1,103 |
| Fluocinolone Acetonide Oil | 25 | $956 |
| Ofloxacin | 29 | $917 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 14 | $890 |
| Mometasone Furoate | 24 | $750 |
| Ipratropium Bromide | 45 | $701 |
| Cefdinir | 21 | $498 |
| Azelastine Hcl | 14 | $400 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $339 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 33 | $224 |
| CefuroximeCefuroxime Axetil | 12 | $179 |
| Famotidine | 12 | $136 |
| Omeprazole | 20 | $132 |
| Methylprednisolone | 15 | $79 |
Paid to pharmacies, not to this prescriber.
Other medical in Davenport
- Kathryn HuberDavenport$4K
- Paulette OngDavenport$4K
- Nicole LuszczykDavenport$685
- Patricia ArasonWest Des Moines$119K
- Maria SonnackIowa City$100K
- Kristin BabbAtlantic$16K
- Laura QuinnetteCouncil Bluffs$14K
- Laurie HughellUrbandale$9K
- Elizabeth McCullochWest Des Moines$6K
- Jordan GreinerPella$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.